Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cephalalgia

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0333102412468340PMID 23197351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura

  2012cited by this paper
• Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery

  2011cited by this paper
• Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study

  2011cited by this paper
• Diencephalic and brainstem mechanisms in migraine

  2011cited by this paper
• Pharmacological and expression profile of the prostaglandin I(2) receptor in the rat craniovascular system.

  2011cited by this paper
• New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.

  2010cited by this paper
• Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs

  2010cited by this paper
• Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine

  2010influential reference
• Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

  2010cited by this paper
• Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura

  2010cited by this paper
• Origin of pain in migraine: evidence for peripheral sensitisation.

  2009cited by this paper
• PACAP38 induces migraine-like attacks in patients with migraine without aura.

  2009cited by this paper
• Prostaglandin E2 (PGE2) Induces Headache in Healthy Subjects

  2009influential reference
• Does the Unfavorable Pharmacokinetic and Pharmacodynamic Profile of the iNOS Inhibitor GW273629 Lead to Inefficacy in Acute Migraine?

  2009cited by this paper
• Migraine: where and how does the pain originate?

  2009cited by this paper
• Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine

  2008cited by this paper
• Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin.

  2005cited by this paper
• Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig.

  2005cited by this paper
• Peptidergic and non-peptidergic innervation and vasomotor responses of human lenticulostriate and posterior cerebral arteries.

  2004cited by this paper
• In-depth characterization of CGRP receptors in human intracranial arteries.

  2003cited by this paper
• The Effect of Nitric Oxide Synthase Inhibition on Histamine Induced Headache and Arterial Dilatation in Migraineurs

  2003cited by this paper
• Migraine can be induced by sildenafil without changes in middle cerebral artery diameter.

  2003cited by this paper
• Stimulation of α2 Adrenoceptors Dilates the Rat Middle Cerebral Artery

  1996cited by this paper
• Stimulation of alpha 2 adrenoceptors dilates the rat middle cerebral artery.

  1996cited by this paper
• Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.

  1993cited by this paper
• Extracerebral manifestations in migraine. A peptidergic involvement?

  1990cited by this paper
• Characterization of histamine receptors in isolated human cerebral arteries

  1988cited by this paper
• Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in human cerebral arteries.

  1984cited by this paper
• Responses of Isolated Feline and Human Cerebral Arteries to Prostacyclin and Some of its Metabolites

  1983cited by this paper
• Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

  1977cited by this paper

• PACAP versus CGRP in migraine: From mouse models to clinical translation

  2025cites this paper
• Migraine: Advances in the Pathogenesis and Treatment

  2023influential citation
• Cellular and Molecular Roles of Immune Cells in the Gut-Brain Axis in Migraine

  2023cites this paper
• Future targets for migraine treatment beyond CGRP

  2023cites this paper
• Brain barriers and their potential role in migraine pathophysiology

  2022influential citation
• Role of PACAP in migraine: An alternative to CGRP?

  2022influential citation
• Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis

  2022influential citation
• Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain

  2022cites this paper
• Alzheimer's Aβ assembly binds sodium pump and blocks endothelial NOS activity via ROS-PKC pathway in brain vascular endothelial cells

  2021influential citation
• Vascular-cognitive impairment after chronic high-thoracic spinal cord injury

  2020cites this paper
• Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers

  2020influential citation
• Estrogen receptors α, β and GPER in the CNS and trigeminal system - molecular and functional aspects

  2020cites this paper
• Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers

  2018cites this paper
• PACAP and its receptors in cranial arteries and mast cells

  2018cites this paper
• Apelin Reduces Nitric Oxide–Induced Relaxation of Cerebral Arteries by Inhibiting Activation of Large-Conductance, Calcium-Activated K Channels

  2018cites this paper
• Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine

  2018cites this paper
• Regulation of Vascular Tone in Cerebral and Coronary Arteries by Apelin/APJ Receptor Mechanisms

  2018cites this paper
• Cholinergic Nociceptive Mechanisms in Rat Meninges and Trigeminal Ganglia: Potential Implications for Migraine Pain

  2017cites this paper
• PACAP38 in human models of primary headaches

  2017cites this paper
• PACAP38: Emerging Drug Target in Migraine and Cluster Headache

  2017cites this paper
• Parasympathetic Cholinergic and Neuropeptide Mechanisms of Migraine

  2016cites this paper
• Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: a practical human model to study Alzheimer's disease vasculopathy.

  2014cites this paper
• Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds

  2014influential citation
• PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.

  2014cites this paper
• Automated Detection and Measurement of Isolated Retinal Arterioles by a Combination of Edge Enhancement and Cost Analysis

  2014cites this paper
• PACAP-induced migraine: a possible CNS effect?

  2014cites this paper
• Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.

  2014cites this paper
• VIP/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium.

  2013cites this paper
• Role of VIP/PACAP in primary headaches

  2013cites this paper